Literature DB >> 20149061

Comparing dose-response measurements of oral habits on oral leukoplakia and oral submucous fibrosis from a community screening program.

Yi-Hsin Yang1, Pei-Shan Ho, Huey-Mei Lu, I-Yueh Huang, Chung-Ho Chen.   

Abstract

BACKGROUND: Many studies have reported that the interaction and dose-response effects of betel quid chewing, tobacco smoking and alcohol drinking habits are important risk factors for oral cancer and precancerous lesions or conditions. These results are useful for comparing statistics, but may not be informative for personal disease-related information.
METHODS: This study used data from a community screening program to evaluate the dose-response effects of daily frequency and duration from oral habits in Taiwan. The receiver operating characteristic (ROC) curves were further used to compare exposure measurements on indicating the occurrence of lesions/conditions.
RESULTS: Our results showed that the highest prevalence was found in leukoplakia (11.1%) and followed by oral submucous fibrosis (OSF, 4.4%). Betel quid chewing habit was found to have dose-response effects on leukoplakia and OSF, cigarette smoking habit only has the dose-response effect on leukoplakia, and alcohol drinking was not associated with both oral precancers. The daily frequency of chewing habit is a better indicator than other dose-response measurements for the occurrence of precancers. In addition, the cut-off points of two to five counts per day have about 60-82% of sensitivities and 79-88% of specificities.
CONCLUSIONS: The cut-off points from ROC curves can provide an informative message to people with oral habits and their chances of developing diseases. High daily frequency of chewing can lead to excessive irritation to oral mucosa. Although the tobacco is never added to chewing quid in Taiwan, intensive irritation may play an important role in developing oral precancers in Taiwan.

Entities:  

Mesh:

Year:  2010        PMID: 20149061     DOI: 10.1111/j.1600-0714.2009.00820.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  Population burden of betel quid abuse and its relation to oral premalignant disorders in South, Southeast, and East Asia: an Asian Betel-quid Consortium Study.

Authors:  Chien-Hung Lee; Albert Min-Shan Ko; Saman Warnakulasuriya; Tian-You Ling; Palandage Sunethra Rajapakse; Rosnah Binti Zain; Salah Osman Ibrahim; Shan-Shan Zhang; Han-Jiang Wu; Lin Liu; Budi Utomo; Supun Amila Warusavithana; Ishak Abdul Razak; Norlida Abdullah; Prashanta Shrestha; Tien-Yu Shieh; Cheng-Fang Yen; Ying-Chin Ko
Journal:  Am J Public Health       Date:  2012-01-19       Impact factor: 9.308

Review 2.  Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis.

Authors:  Nicola Cirillo; Peter Hung Duong; Wee Teng Er; Casey Thao Nhi Do; Manikkuwadura Eranda Harshan De Silva; Yining Dong; Sok Ching Cheong; Elizabeth Fitriana Sari; Michael J McCullough; Pangzhen Zhang; Stephen S Prime
Journal:  Biomolecules       Date:  2022-05-02

3.  Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence.

Authors:  H K Amarasinghe; N W Johnson; R Lalloo; M Kumaraarachchi; S Warnakulasuriya
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

4.  Betel quid, chewing habits and difficult intubation: A case report and critical appraisal of evidence for practice.

Authors:  P L Narendra; Harihar V Hegde; T K Vijaykumar; Samson Nallamilli
Journal:  Anesth Essays Res       Date:  2015 Jan-Apr

5.  Analysis of plasma lipid peroxidation and antioxidant enzymes status in patients of oral leukoplakia: A case control study.

Authors:  Kumar Chandan Srivastava; Deepti Shrivastava
Journal:  J Int Soc Prev Community Dent       Date:  2016-12

Review 6.  Oral submucous fibrosis and its dermatological relation.

Authors:  Fareedi Mukram Ali; Ashok Patil; Kishor Patil; M C Prasant
Journal:  Indian Dermatol Online J       Date:  2014-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.